GO Term | Evidence Code | PMID |
---|---|---|
regulation of meiotic nuclear division | ||
intracellular calcium ion homeostasis |
|
|
response to xenobiotic stimulus | ||
cellular response to electrical stimulus | ||
regulation of transcription, DNA-templated |
|
GO Term | Evidence Code | PMID |
---|---|---|
DNA binding |
|
|
integrin binding | ||
zinc ion binding |
|
|
nuclear androgen receptor binding | ||
protein folding chaperone |
|
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:5672 | large intestine cancer | |
DOID:5675 | cribriform carcinoma | |
DOID:5679 | retinal disease | |
DOID:5702 | pleomorphic liposarcoma | |
DOID:5744 | ovary serous adenocarcinoma | |
DOID:5773 | oral submucous fibrosis | |
DOID:5825 | adult lymphoma | |
DOID:5844 | myocardial infarction | |
DOID:5854 | silent myocardial infarction | |
DOID:6000 | congestive heart failure |
HPO ID | HPO Term |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0000505 | Visual impairment |
HP:0000952 | Jaundice |
HP:0000967 | Petechiae |
HP:0000978 | Bruising susceptibility |
HP:0000979 | Purpura |
HP:0000980 | Pallor |
HP:0001028 | Hemangioma |
HP:0001082 | Cholecystitis |
HP:0001394 | Cirrhosis |
Disease ID | Disease Name |
---|---|
ORPHA:824 |
|
OMIM:254450 |
|
ORPHA:3318 |
|
OMIM:187950 |
|
ORPHA:131 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
115555116 | GADMO06582 | ||
379788 | Xenbase:XB-GENE-1018219 | ||
380458 | Xenbase:XB-GENE-17330280 | ||
407962 | Xenbase:XB-GENE-1018213 | ||
100489027 | Xenbase:XB-GENE-6258823 | ||
120638088 | ORNAN30344 | ||
100918092 | SARHA09071 | ||
100401971 | CALJA23387 | ||
102121336 | MACFA17371 | ||
716910 | MACMU20882 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024